![The Psychopharmacology of Fluoxetine: Mechanism of Action, Indications, Pharmacokinetics and Dosing - Psychopharmacology Institute The Psychopharmacology of Fluoxetine: Mechanism of Action, Indications, Pharmacokinetics and Dosing - Psychopharmacology Institute](https://cdn.psychopharmacologyinstitute.com/wpengine/uploads/fluoxetine_psychopharmacology_16-1024x576.png)
The Psychopharmacology of Fluoxetine: Mechanism of Action, Indications, Pharmacokinetics and Dosing - Psychopharmacology Institute
![Fluoxetine for the Treatment of Childhood Anxiety Disorders - Journal of the American Academy of Child & Adolescent Psychiatry Fluoxetine for the Treatment of Childhood Anxiety Disorders - Journal of the American Academy of Child & Adolescent Psychiatry](https://www.jaacap.org/cms/attachment/9ea16f99-00d2-4521-8dd3-d5280500cbf6/gr1_lrg.gif)
Fluoxetine for the Treatment of Childhood Anxiety Disorders - Journal of the American Academy of Child & Adolescent Psychiatry
![Toxics | Free Full-Text | Effect of Low and High Doses of Two Selective Serotonin Reuptake Inhibitors on Pregnancy Outcomes and Neonatal Mortality Toxics | Free Full-Text | Effect of Low and High Doses of Two Selective Serotonin Reuptake Inhibitors on Pregnancy Outcomes and Neonatal Mortality](https://www.mdpi.com/toxics/toxics-10-00011/article_deploy/html/images/toxics-10-00011-g001.png)
Toxics | Free Full-Text | Effect of Low and High Doses of Two Selective Serotonin Reuptake Inhibitors on Pregnancy Outcomes and Neonatal Mortality
![The Psychopharmacology of Fluoxetine: Mechanism of Action, Indications, Pharmacokinetics and Dosing - Psychopharmacology Institute The Psychopharmacology of Fluoxetine: Mechanism of Action, Indications, Pharmacokinetics and Dosing - Psychopharmacology Institute](https://cdn.psychopharmacologyinstitute.com/wpengine/uploads/fluoxetine_psychopharmacology_15-1024x576.png)
The Psychopharmacology of Fluoxetine: Mechanism of Action, Indications, Pharmacokinetics and Dosing - Psychopharmacology Institute
![Sex-Specific Effects of Chronic Fluoxetine Treatment on Neuroplasticity and Pharmacokinetics in Mice | Journal of Pharmacology and Experimental Therapeutics Sex-Specific Effects of Chronic Fluoxetine Treatment on Neuroplasticity and Pharmacokinetics in Mice | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/332/1/266/F1.large.jpg)
Sex-Specific Effects of Chronic Fluoxetine Treatment on Neuroplasticity and Pharmacokinetics in Mice | Journal of Pharmacology and Experimental Therapeutics
![Daily Injections of Fluoxetine Induce Dose-Dependent Desensitization of Hypothalamic 5-HT1A Receptors: Reductions in Neuroendocrine Responses to 8-OH-DPAT and in Levels of Gz and Gi Proteins | Journal of Pharmacology and Experimental Therapeutics Daily Injections of Fluoxetine Induce Dose-Dependent Desensitization of Hypothalamic 5-HT1A Receptors: Reductions in Neuroendocrine Responses to 8-OH-DPAT and in Levels of Gz and Gi Proteins | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/288/1/98/F1.large.jpg)
Daily Injections of Fluoxetine Induce Dose-Dependent Desensitization of Hypothalamic 5-HT1A Receptors: Reductions in Neuroendocrine Responses to 8-OH-DPAT and in Levels of Gz and Gi Proteins | Journal of Pharmacology and Experimental Therapeutics
![Eighteen-year-old man with autism, obsessive compulsive disorder and a SHANK2 variant presents with severe anorexia that responds to high-dose fluoxetine | BMJ Case Reports Eighteen-year-old man with autism, obsessive compulsive disorder and a SHANK2 variant presents with severe anorexia that responds to high-dose fluoxetine | BMJ Case Reports](https://casereports.bmj.com/content/casereports/2018/bcr-2018-225119/F1.large.jpg)
Eighteen-year-old man with autism, obsessive compulsive disorder and a SHANK2 variant presents with severe anorexia that responds to high-dose fluoxetine | BMJ Case Reports
![Reduced Motivation in Perinatal Fluoxetine-Treated Mice: A Hypodopaminergic Phenotype | Journal of Neuroscience Reduced Motivation in Perinatal Fluoxetine-Treated Mice: A Hypodopaminergic Phenotype | Journal of Neuroscience](https://www.jneurosci.org/content/jneuro/41/12/2723/F1.large.jpg)
Reduced Motivation in Perinatal Fluoxetine-Treated Mice: A Hypodopaminergic Phenotype | Journal of Neuroscience
![Reduced Motivation in Perinatal Fluoxetine-Treated Mice: A Hypodopaminergic Phenotype | Journal of Neuroscience Reduced Motivation in Perinatal Fluoxetine-Treated Mice: A Hypodopaminergic Phenotype | Journal of Neuroscience](https://www.jneurosci.org/content/jneuro/41/12/2723/F6.large.jpg)
Reduced Motivation in Perinatal Fluoxetine-Treated Mice: A Hypodopaminergic Phenotype | Journal of Neuroscience
![Prenatal fluoxetine has long-lasting, differential effects on respiratory control in male and female rats | Journal of Applied Physiology Prenatal fluoxetine has long-lasting, differential effects on respiratory control in male and female rats | Journal of Applied Physiology](https://journals.physiology.org/cms/10.1152/japplphysiol.00020.2022/asset/images/medium/jappl-00020-2022r01.png)
Prenatal fluoxetine has long-lasting, differential effects on respiratory control in male and female rats | Journal of Applied Physiology
![Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis - The Lancet Psychiatry Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis - The Lancet Psychiatry](https://www.thelancet.com/cms/attachment/36844a58-67d6-4241-9a0e-b134c8078cc5/gr2_lrg.jpg)